- Home
- NVCT vs ECBK Comparison
NVCT vs ECBK Comparison
Compare NVCT & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- ECBK
- Stock Information
- Founded
- NVCT 2020
- ECBK 1919
- Country
- NVCT United States
- ECBK United States
- Employees
- NVCT N/A
- ECBK N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- ECBK Banks
- Sector
- NVCT Health Care
- ECBK Finance
- Exchange
- NVCT Nasdaq
- ECBK Nasdaq
- Market Cap
- NVCT 119.4M
- ECBK 138.6M
- IPO Year
- NVCT 2022
- ECBK N/A
- Fundamental
- Price
- NVCT $4.90
- ECBK $14.96
- Analyst Decision
- NVCT Strong Buy
- ECBK
- Analyst Count
- NVCT 1
- ECBK 0
- Target Price
- NVCT $21.00
- ECBK N/A
- AVG Volume (30 Days)
- NVCT 303.6K
- ECBK 7.9K
- Earning Date
- NVCT 11-05-2024
- ECBK 10-24-2024
- Dividend Yield
- NVCT N/A
- ECBK N/A
- EPS Growth
- NVCT N/A
- ECBK N/A
- EPS
- NVCT N/A
- ECBK 0.39
- Revenue
- NVCT N/A
- ECBK $24,711,000.00
- Revenue This Year
- NVCT N/A
- ECBK N/A
- Revenue Next Year
- NVCT N/A
- ECBK N/A
- P/E Ratio
- NVCT N/A
- ECBK $38.42
- Revenue Growth
- NVCT N/A
- ECBK N/A
- 52 Week Low
- NVCT $4.69
- ECBK $11.39
- 52 Week High
- NVCT $12.10
- ECBK $15.68
- Technical
- Relative Strength Index (RSI)
- NVCT 35.71
- ECBK 50.84
- Support Level
- NVCT $4.75
- ECBK $14.81
- Resistance Level
- NVCT $5.49
- ECBK $15.65
- Average True Range (ATR)
- NVCT 1.14
- ECBK 0.25
- MACD
- NVCT -0.52
- ECBK -0.04
- Stochastic Oscillator
- NVCT 3.02
- ECBK 19.21
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.